• 한국융합학회논문지
• /
• 제11권5호
• /
• pp.241-251
• /
• 2020

항균, 항산화, 항염증 효능의 기능성 원료로써 효능이 확인된 느릅나무 추출물을 포함하는 화장품 개발을 위한 연구와 이 화장품의 아토피피부염과 같은 건조하고 민감한 피부 개선 효능에 대한 연구를 수행하였다. 원료 물질인 느릅나무 초임계 추출박 60%주정 추출물(USCFR)과 초임계 추출물(USCF), 이를 포함하는 예비제형 DKBP-1903 (겔)에 대한 독성시험을 수행한 결과 '무독성'으로 판정되었다. 이를 토대로 조제한 각 제형별 화장품 로션, 크림, 겔에 대한 안정성 시험 결과, 크림과 겔이 더 우수한 안정성을 보였고 안정성이 확보된 두 가지 제형에 대해 아토피 피부염 개선 효능 입증을 위한 화장품 효능시험으로 48시간 보습지속력 시험과 건조함에 의한 소양감개선 시험을 진행한 결과, 크림과 겔 도포 24시간 후 82.9%, 92.32%의 피부각질층 수분함량 개선율을 보였고 2주 후부터 소양감 개선 효과를 나타냈다. 이러한 결과를 통해 크림과 겔 모두 비교적 안전한 보습제로써 건조하고 민감한 피부에 도움을 줄 수 있는 것으로 판단된다.

• 한방안이비인후피부과학회지
• /
• 제27권1호
• /
• pp.1-16
• /
• 2014

Objectives : The aim of this study is to examine the effect of external application containing herbal extracts (Betula platyphyllae Cortex, Viticis Fructus, Agrimoniae herba) to patients with atopic dermatitis. Methods : Twenty patients (experiment group) were treated with the external application containing herbal extracts (Betula platyphyllae Cortex, Viticis Fructus, Agrimoniae herba) and other twenty patients (control group) were treated with normal external application that doesn't contain herbal extracts for 2weeks. We observed comparisons between experiment and control group after 1week, 2weeks. Degrees of severity of atopic dermatitis were measured by SCORAD index (Scoring of Atopic Dermatitis Index). Statistical significance was achieved if the probability was less than 5% (p<0.05). Results : 1. After 1week of external application treatment, SCORAD Index in experiment group was significantly decreased comparing with control group, which is a marginally significant result between two groups. But after 2weeks the experiment group showed no statistically significant result. 2. After 1week of external application treatment, Intensity Criteria (Erythema, Edema/papulation, Total) in experiment group was significantly decreased comparing with control group, which is a statistically significant result between two groups. But after 2weeks the experiment group showed no statistically significant result. 3. After 1week and 2weeks of external application treatment, comparison of changes in Subjective Symptoms (Pruritus, Insomnia) indicated that the experiment group showed no statistically significant result. 4. After 1week of external application treatment, Total Quality of life through Skindex-29 in experiment group was significantly decreased comparing with control group, which is a marginally significant result between two groups. But after 2weeks the experiment group showed no statistically significant result. Conclusions : As a result of applying the external application containing herbal extracts to patients with atopic dermatitis and watching the progress, we can speculate that the external application containing herbal extracts has especially short-term therapeutical effects in mitigating the symptoms of Atopic Dermatitis. Thus, it is concluded and considered that the external application containing herbal extracts can be used by atopic patients effectively with almost no side-effect.

• 한방안이비인후피부과학회지
• /
• 제26권2호
• /
• pp.1-9
• /
• 2013

Background : According to the rising cases of clinical researches with Traditional Korean Medicine for persistent allergic rhinitis patients, the need for developing and applying Pattern diagnosis instrument has been increasing. Objective : This study was done to investigate and pragmatize the Pattern diagnosis instrument for persistent allergic rhinitis patients launched by KFDA in 2008. Methods : Data was collected by structured survey papers from Korean Medicine doctors participate in the Conference of The Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology Society in October 2012. We investigated their representative Patterns(변증) of every questions and used the mean results for assuming agreement rates. The importance order of 8 symptom domains for considering Pattern diagnostic steps were also asked and analyzed for inducing importance rates. Finally based on above two results, we developed weight points of each questions by multiplying agrement percents with importance rates. Results : 50 Korean medicine doctors described the informed consent and survey papers. Response agreement rates of each questions of Pattern diagnosis instruments were analyzed and described in Table 2. Comparing the survey results with diagnostic references, matched percent of 肺胃熱 was the 87.9%, 肺氣虛寒 was 62.5%, 肺脾氣虛 was 62.5% and 腎元虧虛 was 50%. Mean importance rates of rhinorrhea was 7.28, otoscope diagnosis 5.12, obstruction 5.04, sneeze 4.82, symptom duration 4.63, other body condition 3.54, tongue diagnosis 3.02, nasal pruritus 2.86, accordingly. Final importance rates of each questions were assumed, and the range of them was from 1.60 to 4.72, which were listed in Table 5. Conclusion : These results might provide the rational backgrounds and practical methods for developing and utilizing methods of Pattern diagnosis questionnaire for perennial allergic rhinitis.

• 한국임상수의학회지
• /
• 제24권3호
• /
• pp.432-436
• /
• 2007

개 모낭충증의 새로운 치료법을 확립하기 위하여 항생제의 약침과 일반 치료의 병행을 이용한 치료 효과를 조사하였다. 본 연구에서는 모낭충으로 진단된 개 3두를 이용하였다. Enrofloxacin의 약침을 폐수(BL13) 위중(BL40), 대추(GV14), 족삼리(ST36), 합곡(LI04), 곡지(LI11) 및 삼음교(SP06)의 혈위에 각각 5주간 실시하였다. 또한 일반 치료법인 invermectin과 0.05% amitraz 약욕을 5주간 추가로 실시하였다. 소양증, 찰과상, 홍반 및 탈모와 같은 임상증상은 약침과 일반치료에 의해서 치료 전에 비하여 현저하게 완화되었다. Case 1은 4주 후에 완치되었고, case 2는 5주 후에 증상이 약간 잔존하였으며, 그리고 case 3은 5주 후에 완치되었다. 혈중 백혈구 수는 치료와 더불어 모든 케이스에서 감소하는 경향을 보였으나, 호중구/림프구 비율은 일정한 경향을 나타내지 않았다. 5주째 병리조직 검사 소견상에서 case 1과 case 3은 뚜렷한 병리조직학적 변화가 관찰되지 않았으나, case 2는 경도의 변화가 관찰되었다. 결론적으로 개 모낭충에 이환된 본 환축들은 항생제 약침과 일반 치료법의 병행으로 양호한 치료반응을 나타낸 증례이었다.

• 한방안이비인후피부과학회지
• /
• 제23권1호
• /
• pp.199-214
• /
• 2010

Objective : Atopic dermatitis (AD) may profoundly affect patient's quality of life (QOL), and also cause economic impact. The aim of our study was to evaluate the quality of life and the economic impact of adult atopic dermatitis patient in Seoul. We also evaluate the relationship of QOL and economic impact with severity of AD. Methods : 30 adult atopic dermatitis patient were included and evaluated by using the SCORAD Index and EASI. Patients were asked to fill in the questionnaires about their quality of life and financial costs during the past year by AD. Data about sleep disturbance and pruritus were also obtained. Pearson's correlation were used for statistical analysis. Results : 1. Among 30 patients, women were 19(63.3%), men were 11(36.7%). The mean age of the patients were 27.3 years old, patients between the ages of 17 and 30 years were 23, over 30 were seven. 2. The mean score of Objective SCORAD was $32.89{\pm}7.30$, Subjective SCORAD was $8.13{\pm}3.53$ and EASI was $9.15{\pm}6.90$이었다. 3. The mean score of Skindex-29 was $28.26{\pm}7.58$, DLQI was $10.17{\pm}5.55$. 4. By analyzing the questionnaire, a monthly average cost of 583,200 won for each patient was determined. Direct cost was 236,800 won and indirect cost was 346,300 won. 5. By analyzing the correlation between the severity of AD and QOL, Objective SCORAD and EASI were positively correlated with QOL(Skindex-29, DLQI) but not significant, meanwhile subjective SCORAD were significantly and positively correlated with QOL(Skindex-29, DLQI). 6. By analyzing the correlation between the severity of AD and economic impact, Objective SCORAD were significantly and positively correlated with direct cost and indirect cost. Also, EASI were significantly and positively correlated with direct cost and oriental medical hospital visits. Conclusions : The above results show that the QOL of the patients with atopic dermatitis is significantly related to their disease severity. Atopic dermatitis patients pay 583,200 won a month, and the economic impact of the patients is significantly related to their disease severity.

• Journal of Acupuncture Research
• /
• 제36권4호
• /
• pp.245-250
• /
• 2019

Background: This study was designed to evaluate the clinical safety of Bee Venom (BV) pharmacopuncture at craniofacial acupuncture points. Methods: This was a retrospective study of 108 patients diagnosed with peripheral facial paralysis, trigeminal neuralgia, or facial spasm who were admitted to Kyung Hee University Korean Medicine Hospital at Gangdong, from April 1st, 2017 to August 30th, 2017. Patients were allocated into either, Group 1 (the non-allergy group of patients who did not have an allergic reaction to BV) or Group 2, the group who had allergic reactions to BV. To evaluate the clinical safety of BV pharmacopuncture after each treatment, several criteria were used to measure any side effects: outcome, Common Terminology Criteria for Adverse Events scale, Mueller HL scale, treatment decision after adverse reaction, causality, measures performed for patients with adverse reactions, and efficacy assessment. Results: BV pharmacopuncture delivered in 0.1-0.2 mL at a concentration of 1:30,000 at the craniofacial acupuncture points, showed no statistically significant differences in baseline characteristics between non-allergy Group 1 and allergy Group 2. Amongst the 108 patients, 11 reported side effects after BV pharmacopuncture treatment. These adverse events included rash (n = 7), pruritus (n = 5), swelling (n = 1), vesicles (n = 1), erythema (n = 1), and hives (n = 1). All side effects resolved without sequelae. Conclusion: In this study, BV pharmacopuncture delivered at low doses at the craniofacial acupuncture points, resulted in 10% of patients experiencing non serious side effects suggesting that BV pharmacopuncture was clinically well tolerated.

• 한방안이비인후피부과학회지
• /
• 제34권4호
• /
• pp.210-227
• /
• 2021

Objectives : The purpose of this study is to report the Korean medicine treatment on whole-body nummular eczema. Methods : This case study was conducted with a 66-year-old female patient who has whole-body nummular eczema treated by Korean medicine. She was treated from 2021.3.30 to 2021.6.28. During the treatment, the two herbal medicines were changed depending on the patient's condition. We treated her with herbal medicine, herbal external preparations and acupuncture treatment. For the evaluation of the results, we used photo comparison, VAS, and DLQI. Results : After the treatment, the nummular eczema lesions of patient was remarkably improved. Also, the VAS grade of other symptoms such as pruritus, burning sense, oozing, crusting and erythema were decreased and DLQI score changed from 27 to 2. Conculsions : This study suggests that Korean medicine treatments are effective for patient with recurrent nummular eczema.

• 한국응용과학기술학회지
• /
• 제38권5호
• /
• pp.1292-1301
• /
• 2021

본 연구는 섬애약쑥(Artemisia argyi H.)의 항가려움증 활성 가능성을 확인하기 위한 연구로써 가려움증 관련인자 등을 측정하였다. 섬애약쑥은 열수로 추출(Artemisia argyi H. distilled water extract 이하, AAD)하여 MTT assay로 세포독성을 측정하였고 항 가려움증 활성을 확인하기 위하여 IL-4와 IL-31 관련 전사인자 발현 및 단백질 생성을 측정하였으며, 히스타민의 발현을 측정하였다. 그 결과 25, 50, 100 ㎍/㎖의 농도에서는 유의한 세포독성이 나타나지 않는 것을 확인하였다. 가려움증 연관 유전인자인 IL4의 경우 25 ㎍/㎖의 농도에서 약 12%, 50 ㎍/㎖의 농도에서 약 26%, 100 ㎍/㎖의 농도에서 약 61%로 유의하게 감소하였으며, IL31의 경우 50 ㎍/㎖의 농도에서 약 33%, 100 ㎍/㎖의 농도에서 약 33%로 유의하게 감소하였다. 연관된 단백질 측정의 경우 각각 50 ㎍/㎖와 100 ㎍/㎖의 농도에서 IL-4는 약 34% 및 약 69%, IL-31은 약 36% 및 약 37% 유의하게 감소하였다. 이 결과는 ADD가 항가려움증을 위한 소재로써 가능성을 보여 소재 개발을 위한 기초자료로 제공될 수 있을 것으로 사료된다.

• 대한화장품학회지
• /
• 제46권4호
• /
• pp.361-369
• /
• 2020

아토피성 피부염은 피부장벽 기능장애, 염증 및 만성 소양증을 특징으로 하는 다인성의 염증성 피부질환이다. 아토피성 피부염은 유전적, 면역학적, 환경적 요인 등의 복합적인 요인으로 피부장벽 기능과 면역기능의 장애를 유발한다고 알려져 있다. 고삼 추출물은 중국전통의학에서 사용되고 있으나, 이의 항아토피 효능에 대한 연구는 거의 진행되지 않았다. 본 연구에서는 아토피성 피부염의 주요 증상인 피부장벽 기능과 면역이상 개선에 대한 고삼추출물의 효과를 평가하였다. 고삼추출물은 피부장벽 기능에서 중요한 역할을 하는 각질세포막의 형성을 강화하는 결과를 나타내었다. 또한 피부의 보습작용에 있어서 중요한 히알루론산의 발현을 증가시키는 결과를 나타내었다. 아토피성 피부염 병변에서 특이적으로 증가하는 황색포도상구균에 대한 고삼추출물의 효능도 확인하였으며, 고삼추출물이 황색포도상구균으로부터 유도된 전염증성사이토카인의 생성을 억제함을 확인하였다. 또한 피부 스트레스 등으로 부터 생성되는 신경전달 물질인 substance P에 의해 유도된 전염증성사이토카인의 발현도 억제하는 것을 확인하였다. 이러한 결과들은 고삼추출물이 피부장벽기능과 면역반응 개선을 통해 아토피 피부염 치료에 사용될 수 있는 잠재적 후보물질임을 제시한다.

• 한방안이비인후피부과학회지
• /
• 제36권3호
• /
• pp.42-73
• /
• 2023

Objectives : In order to investigate the current status of recent clinical evidence related to complementary and alternative medicine(CAM) treatment for burns and to inform research and treatment strategies for future, we publish a scoping review(ScR) of randomized controlled trials(RCTs). Methods : The research question of the ScR was "Are there any RCTs of CAM treatment for burn?". RCTs published from 2000 to 2022 were identified in 7 databases(PubMed, Cochrane, CNKI, OASIS, RISS, KCI, KMbase) in March 2023. Data were tabulated and analyzed descriptively with respect to the research questions. Results : 41 RCTs were included. 21(51.2%) were conducted in China, 13(31.7%) in Iran. The main treatment criteria were herbal medicine in 28 cases, acupuncture in 9 cases, chuna therapy in 4 cases, and psychotherapy in 3 cases. Among the herbal medicine, there were 19 topical medications, 5 injections(intravenous pharmacopuncture), 4 aerosol drugs(aromatherapy), and 1 oral drug. Among the acupuncture, there were 4 plum blossom needles(seven-star needles), 2 wrist-ankle acupunctures, 2 press needles, and 1 electroacupuncture. CAM treatments were effective in treating burns. It reduced pain and pruritus at the burn site, helped recovery and management of the donor site, reduced anxiety and pain during dressing change, improved hematological problems and vital signs, and finally lowered the mortality rate. CAM treatments also lowered health care costs. Conclusions : CAM treatments for burns is prospective, and that it deserves to make high-quality studies including additional large-scale RCTs.